159 related articles for article (PubMed ID: 29393030)
21. Cosmetic iris implants.
Mamalis N
J Cataract Refract Surg; 2012 Mar; 38(3):383. PubMed ID: 22340602
[No Abstract] [Full Text] [Related]
22. [Corneal decompensation secondary to cosmetic iris implant, treated by DMEK].
Trinh L; Brasnu E; Baudouin C; Bouheraoua N
J Fr Ophtalmol; 2019 Mar; 42(3):e105-e106. PubMed ID: 30850202
[No Abstract] [Full Text] [Related]
23. Artificial iris devices: benefits, limitations, and management of complications.
Koch KR; Heindl LM; Cursiefen C; Koch HR
J Cataract Refract Surg; 2014 Mar; 40(3):376-82. PubMed ID: 24581771
[TBL] [Abstract][Full Text] [Related]
24. Yoga-induced uveitis glaucoma hyphema syndrome.
Mammo D; Page MA; Olson JH
Digit J Ophthalmol; 2021 Feb; 26(4):46-48. PubMed ID: 33867882
[TBL] [Abstract][Full Text] [Related]
25. Complications related to the explantation of cosmetic iris implants.
Moshirfar M; Kim G
J Cataract Refract Surg; 2012 Oct; 38(10):1876-7; author reply 1877-8. PubMed ID: 22999624
[No Abstract] [Full Text] [Related]
26. Complications of cosmetic iris implants.
Thiagalingam S; Tarongoy P; Hamrah P; Lobo AM; Nagao K; Barsam C; Bellows R; Pineda R
J Cataract Refract Surg; 2008 Jul; 34(7):1222-4. PubMed ID: 18571095
[TBL] [Abstract][Full Text] [Related]
27. Postoperative results of cosmetic iris implants.
Galvis V; Tello A; Corrales MI
J Cataract Refract Surg; 2016 Oct; 42(10):1518-1526. PubMed ID: 27839608
[TBL] [Abstract][Full Text] [Related]
28. Serial intracameral bevacizumab for uveitis-glaucoma-hyphema syndrome: a case report.
Rech L; Heckler L; Damji KF
Can J Ophthalmol; 2014 Dec; 49(6):e160-2. PubMed ID: 25433757
[No Abstract] [Full Text] [Related]
29. [Acute angle-closure attack secondary to BrightOcular(©) cosmetic iris implant and subsequent subluxation of contralateral iris implant].
Le Dû B; Boukhrissa M; Nordmann JP
J Fr Ophtalmol; 2016 Jun; 39(6):e141-4. PubMed ID: 27131426
[No Abstract] [Full Text] [Related]
30. [Bilateral explantation of iris implants due to pigment dispersion syndrome (PDS) and corneal decompensation after cosmetic iris implantation (BrightOcular)].
Varna-Tigka K; Löffler F; Kohnen T
Ophthalmologe; 2020 Nov; 117(11):1116-1120. PubMed ID: 32025791
[TBL] [Abstract][Full Text] [Related]
31. Medical and surgical management of spontaneous hyphaema secondary to immune thrombocytopenia.
McDonald CJ; Raafat A; Mills MJ; Rumble JA
Br J Ophthalmol; 1989 Nov; 73(11):922-5. PubMed ID: 2605148
[TBL] [Abstract][Full Text] [Related]
32. Severe glaucoma and vision loss due to cosmetic iris implants.
McCall D; Hamilton A; Grigg J; Chau-Vo S
Med J Aust; 2015 Mar; 202(4):182. PubMed ID: 25716598
[No Abstract] [Full Text] [Related]
33. Surgical technique for explantation of cosmetic anterior chamber iris implants.
Arjmand P; Gooi P; Ahmed II
J Cataract Refract Surg; 2015 Jan; 41(1):18-22. PubMed ID: 25532632
[TBL] [Abstract][Full Text] [Related]
34. Uveitis-glaucoma-hyphaema (UGH) syndrome treated with local laser iridoplasty.
Walland MJ
Clin Exp Ophthalmol; 2017 Aug; 45(6):647-648. PubMed ID: 28182311
[No Abstract] [Full Text] [Related]
35. Five-slice technique for the explantation of complicated BrightOcular© cosmetic iris implants.
Shalash A; El Bahrawy M
Int Ophthalmol; 2020 Jun; 40(6):1565-1570. PubMed ID: 32166580
[TBL] [Abstract][Full Text] [Related]
36. Risks of cosmetic iris implantation.
Li S; Noble J; Lloyd JC
Can J Ophthalmol; 2012 Dec; 47(6):e50-1. PubMed ID: 23217517
[No Abstract] [Full Text] [Related]
37. Uveitis-glaucoma-hyphema syndrome associated with recurrent vitreous hemorrhage.
Alfaro-Juárez A; Vital-Berral C; Sánchez-Vicente JL; Alfaro-Juárez A; Muñoz-Morales A
Arch Soc Esp Oftalmol; 2015 Aug; 90(8):392-4. PubMed ID: 25817966
[TBL] [Abstract][Full Text] [Related]
38. Secondary pigmentary glaucoma following cosmetic laser treatment to alter iris colour.
Swampillai AJ; Sherman T; Garg A; Tan IJ; Sheng Lim K
Cont Lens Anterior Eye; 2023 Apr; 46(2):101754. PubMed ID: 36175318
[TBL] [Abstract][Full Text] [Related]
39. Elevated Intraocular Pressure and Endothelial Cell Loss Following Iris Color Change.
Ali MH; Traish AS
JAMA Ophthalmol; 2016 Aug; 134(8):939-40. PubMed ID: 27309351
[No Abstract] [Full Text] [Related]
40. Transient monocular visual loss due to uveitis-glaucoma-hyphaema (UGH) syndrome.
Cates CA; Newman DK
J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):131-2. PubMed ID: 9667576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
